AllianceBernstein’s Embecta EMBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.31M Sell
110,687
-7,112
-6% -$74.1K ﹤0.01% 2223
2025
Q4
$1.4M Sell
117,799
-1,111
-0.9% -$14.7K ﹤0.01% 2190
2025
Q3
$1.68M Buy
118,910
+25,442
+27% +$322K ﹤0.01% 2106
2025
Q2
$906K Sell
93,468
-13,962
-13% -$157K ﹤0.01% 2352
2025
Q1
$1.37M Buy
107,430
+6,974
+7% +$112K ﹤0.01% 2087
2024
Q4
$2.07M Sell
100,456
-15,768
-14% -$258K ﹤0.01% 1939
2024
Q3
$1.64M Buy
116,224
+52,390
+82% +$762K ﹤0.01% 2072
2024
Q2
$798K Sell
63,834
-23
-0% -$279 ﹤0.01% 2419
2024
Q1
$847K Sell
63,857
-42
-0.1% -$651 ﹤0.01% 2354
2023
Q4
$1.21M Sell
63,899
-45
-0.1% -$738 ﹤0.01% 2183
2023
Q3
$962K Sell
63,944
-89
-0.1% -$1.67K ﹤0.01% 2262
2023
Q2
$1.38M Sell
64,033
-101
-0.2% -$2.75K ﹤0.01% 2103
2023
Q1
$1.8M Sell
64,134
-15,219
-19% -$432K ﹤0.01% 1928
2022
Q4
$2.01M Buy
79,353
+101
+0.1% +$3.08K ﹤0.01% 1918
2022
Q3
$2.28M Sell
79,252
-1,689
-2% -$50K ﹤0.01% 1803
2022
Q2
$2.05M Buy
+80,941
New +$2.33M ﹤0.01% 1946

Other funds holding EMBC

AllianceBernstein's EMBC Position: Q1 2026 in Review

AllianceBernstein reduced its Embecta (EMBC) stake by 6% in Q1 2026, selling an estimated $74.1K and leaving 110,687 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2223.

AllianceBernstein first reported a position in EMBC in Q2 2022 and has held it in 16 quarters since. The position peaked at $2.28M in Q3 2022. 337 funds tracked by Wall St. Rank hold EMBC as of Q1 2026.

  • AllianceBernstein held 110,687 shares of Embecta worth $1.31M as of Q1 2026.
  • AllianceBernstein sold 7,112 Embecta shares in Q1 2026, an estimated $74.1K.
  • Embecta made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2223 holding.
  • AllianceBernstein first reported a position in Embecta in Q2 2022 and has held it in 16 quarters since.
  • AllianceBernstein's Embecta position peaked at $2.28M in Q3 2022.
  • 337 funds tracked by Wall St. Rank held Embecta as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.